TY - JOUR T1 - COVID-19 vaccine efficacy in a rapidly changing landscape JF - Journal of Investigative Medicine JO - J Investig Med SP - 1327 LP - 1328 DO - 10.1136/jim-2022-002520 VL - 70 IS - 6 AU - Stephanie L Baer AU - Sarah Tran Y1 - 2022/08/01 UR - http://hw-f5-jim.highwire.org/content/70/6/1327.abstract N2 - The COVID-19 pandemic has presented new challenges to healthcare infrastructure, virology, vaccinology research, and implementation science. Misinformation concerning vaccines and non-pharmacologic measures to mitigate the spread of COVID-19 has made the study of vaccine efficacy extremely important for both transparency and accountability. The vaccines for COVID-19 were developed with urgency but without compromise of any safety or regulatory measures. They are undoubtedly the most efficacious means of disease mitigation we currently have available. As of this writing, 11.7 billion doses have been given worldwide, with 578 million in the USA alone.1 Unfortunately, due to the nature of the coronavirus, new variants continue to emerge. When dealing with a rapidly changing pathogen, it is essential to continuously review and update the known data, as manuscripts become outdated as soon as the first draft is written. In this issue of Journal of Investigative Medicine, Hirsh et al 2 … ER -